Windtree Therapeutics Inc
NASDAQ:WINT
Balance Sheet
Balance Sheet Decomposition
Windtree Therapeutics Inc
Current Assets | 3.3m |
Cash & Short-Term Investments | 2.5m |
Other Current Assets | 792k |
Non-Current Assets | 26.8m |
PP&E | 1.5m |
Intangibles | 25.3m |
Other Non-Current Assets | 9k |
Current Liabilities | 5m |
Accounts Payable | 1.7m |
Accrued Liabilities | 2.6m |
Other Current Liabilities | 725k |
Non-Current Liabilities | 9.7m |
Other Non-Current Liabilities | 9.7m |
Balance Sheet
Windtree Therapeutics Inc
Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
45
|
39
|
6
|
2
|
11
|
23
|
17
|
22
|
6
|
4
|
|
Cash Equivalents |
45
|
39
|
6
|
2
|
11
|
23
|
17
|
22
|
6
|
4
|
|
Short-Term Investments |
0
|
0
|
0
|
0
|
14
|
0
|
0
|
0
|
0
|
0
|
|
Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Current Assets |
1
|
2
|
2
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
|
Total Current Assets |
46
|
41
|
7
|
2
|
26
|
24
|
18
|
24
|
7
|
5
|
|
PP&E Net |
2
|
1
|
1
|
1
|
1
|
2
|
2
|
3
|
2
|
2
|
|
PP&E Gross |
2
|
1
|
1
|
0
|
0
|
2
|
2
|
3
|
2
|
2
|
|
Accumulated Depreciation |
11
|
9
|
7
|
0
|
0
|
6
|
7
|
7
|
4
|
4
|
|
Intangible Assets |
0
|
0
|
0
|
0
|
77
|
77
|
77
|
32
|
25
|
25
|
|
Goodwill |
0
|
0
|
0
|
0
|
16
|
16
|
16
|
16
|
3
|
0
|
|
Other Long-Term Assets |
0
|
3
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Assets |
0
|
0
|
0
|
0
|
16
|
16
|
16
|
16
|
3
|
0
|
|
Total Assets |
48
N/A
|
44
-7%
|
10
-78%
|
3
-66%
|
119
+3 518%
|
119
0%
|
113
-5%
|
75
-34%
|
38
-49%
|
32
-15%
|
|
Liabilities | |||||||||||
Accounts Payable |
0
|
0
|
2
|
3
|
3
|
2
|
1
|
1
|
0
|
1
|
|
Accrued Liabilities |
6
|
7
|
8
|
4
|
7
|
4
|
5
|
4
|
2
|
2
|
|
Short-Term Debt |
0
|
0
|
0
|
0
|
8
|
0
|
0
|
0
|
0
|
0
|
|
Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Current Liabilities |
1
|
4
|
4
|
5
|
3
|
2
|
0
|
0
|
0
|
1
|
|
Total Current Liabilities |
8
|
11
|
13
|
12
|
21
|
8
|
6
|
5
|
3
|
4
|
|
Long-Term Debt |
20
|
25
|
25
|
15
|
15
|
20
|
17
|
15
|
15
|
15
|
|
Deferred Income Tax |
0
|
0
|
0
|
0
|
16
|
16
|
17
|
7
|
5
|
5
|
|
Other Liabilities |
0
|
0
|
0
|
1
|
0
|
1
|
3
|
6
|
5
|
5
|
|
Total Liabilities |
28
N/A
|
36
+28%
|
39
+7%
|
27
-29%
|
51
+88%
|
44
-14%
|
43
-2%
|
33
-24%
|
28
-15%
|
29
+4%
|
|
Equity | |||||||||||
Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Retained Earnings |
524
|
579
|
619
|
637
|
658
|
685
|
718
|
785
|
825
|
845
|
|
Additional Paid In Capital |
546
|
591
|
593
|
616
|
729
|
763
|
790
|
830
|
838
|
851
|
|
Treasury Stock |
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
|
Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Equity |
19
N/A
|
8
-57%
|
29
N/A
|
24
+17%
|
68
N/A
|
75
+10%
|
70
-7%
|
42
-40%
|
10
-76%
|
3
-66%
|
|
Total Liabilities & Equity |
48
N/A
|
44
-7%
|
10
-78%
|
3
-66%
|
119
+3 518%
|
119
0%
|
113
-5%
|
75
-34%
|
38
-49%
|
32
-15%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
6
|
|
Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|